skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I'm looking for tax-loss proxy ideas for GH and TTD.
Thank you!
Read Answer Asked by Andrew on May 17, 2021
Q: So this new crypto etf has about 60% of weight in its top 10 holdings with Coinbase on top. I'd ask for any initial view on its setup or other comment you may have and whether this may become a preferred way to invest in cryto at some point. Thank you - Ken
Read Answer Asked by Ken on May 14, 2021
Q: Hello Team,
How would you rank AMZN, GOOG and NFLX, given their current prices and a reopening world and why?
Thank You,
Barry
Read Answer Asked by Barry on May 14, 2021
Q: As I watch the growth stocks in my portfolio get crushed I can't help but also feel excited at the buying opportunities that are being created for others I thought I had missed. With the Nasdaq only 1200 points off its high and companies like TWST (down 57%), LMND (down to 60%) or BOMN (down 50%) or NVTA (down 55%) it is undeniable that many of these stocks have been revalued.

My question pertains both to these specific companies and smaller caps in general. Do you think companies like these are close to finding a floor meaning that it is time to start buying in tranches as they inch down or do you consider it more likely that we need a major sell off and full capitulation?

With these specific companies, what would be an entry price that makes sense for each for the first 1/2 and then a full position. (ie buy a 1/2 of LMND at 75 and then full at 60 if it gets there).
Read Answer Asked by Tim on May 13, 2021
Q: AVEO Oncology share price jumped after it got FDA approval for
FOTIVDAŽ (tivozanib) around 2 months ago. It ramped up for this by securing capital, and issued new equity, @ $ 8.00 which was fully subscribed, including all offered additional shares. New Director appointed who seems to be quite an authority on cancer research.

Unfortunately. the Share price dropped after the spike on approval, and has fallen back to old levels. what seems to be the problem ? When do you think, if at all, the price will reach the lofty levels recommended by the Analysts covering it.

Thanks and Appreciate all the advise and guidance you and your team provides.

Rajesh
Read Answer Asked by Rajesh on May 13, 2021
Q: Please rate these cyber security companies as your choice to buy for a 3-5 yr. hold. Any others you would choose?
Read Answer Asked by Terry on May 12, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!